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ABSTRACT: In vivo and in vitro extracted cardiac glycosides of immature seeds (IS) cultures of Thevetia neriifolia 
Jussieu. and T. thevetioides Kunth. were chemically identified. Calli were grown on modified Murashige & Skoog 
(MS) medium supplemented with 1mg/l 2,4-dichlorophenoxyacetic acid  (2,4-D) +3mg/l kinetin (Kin). The content 
of cardiac glycosides in IS cultures of T. neriifolia and T. thevetioides were monitored by HPLC. Two major 
compounds were detected and isolated from IS extracts i.e.  digitoxigenin and thevetin B. The different structures of 
the in vivo and in vitro isolated compounds were verified by means of MS and NMR spectral analysis, as well as 
those compounds were identified and determined using HPLC technique. [Journal of American Science 
2010;6(11):390-395]. (ISSN: 1545-1003). 
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INTRODUCTION 
Thevetia neriifolia Juss. and T. thevetioides 
Kunth. belonging to Apocynaceae family, which are 
commonly known as the dogbane or oleander family 
(Omino and Kokwaro, 1993). Apocynaceae plants 
are distributed in tropical America and the West 
Indies and widely grown in various parts of the world 
for ornamental purpose (Rizk and Al-Nowaihi, 1989; 
Sabira et al. 1993). It has been used in folk medicine 
as a purgative, emetics, and a remedy for intermittent 
fever (Githens, 1948). Moreover, It is having 
cardiotonic activity (Aleshkina and Berezhinskaya, 
1962), anticancer (Cardellina et al. 1993), 
neuroprotection against ischemic stroke, as well as 
insecticidal properties (James et al. 2006). The 
toxicity of Thevetia species attributed  to  their 
cardenolide content in their tissues (Goncalves et al. 
2003; Gaillard et al. 2004; Gaillard et al. 2004). 
Cardiac  glycosides  Cerberin  (monoacetylneriifolin), 
ruvoside and perusitin   were isolated from the seeds 
of Thevetia peruviana (Siddiqu et al. 1992). Abe et 
al., (1994) isolated sixteen cardenolide glycosides 
and one pregnane glycoside from the frozen fresh 
leaves of Thevtia neriifolia. Siddiqui et al (1992) 
isolated neriifoside from the fresh uncrushed leaves 
of Thevetia neriifolia, in addition to four triterpenes; 
oleanolic acid, ursolic acid, α-amyrin acetate and β-
amyrin acetate. Also, cerberoside, 2-O-
acetylcerberoside, neriifolin, thevetin A&B, 
peruvoside, digitoxigenin were isolated (Balsam and 
Kufner 1971; Seitz and Ripphahn 1975; Said, 1985; 
Decosterd et al. 1994). The triterpenes, sterol, Fatty 
acids and flavonoid constituents of Thevetia 
peruviana fruit pericarp and flowers were also 
studied (Qazi et al. 1973; Rao et al. 1975; Schum-
Obasi et al. 1990). 
In vitro culture technology has been proven 
to be effective in some cases for the production of 
secondary metabolites such as taxol (Oksman-
Caldentey and Inzé 2004). Moreover, Dantas et al. 
(1994) studied six strain of T. neriifolia cell 
suspension cultures for cardenolides production.  
Even after two years of subculture, cardenolides 
proved to be present in all these strains.  The 
cardenolides content varied from one strain to 
another according to the nature of the original 
explants. Furthermore, Lopes et al. (2001) reported 
that some compounds found in the intact plant could 
accumulate in cultured cells. Cardenolides of T. 
neriifolia, were accumulated in cultured cells during 
one year of cultivation.   
In the present work, cardiac glycoside in 
seed cultures of T. neriifolia and T. thevetioides were 
identified and compared qualitatively and 
quantitatively with those isolated previously from in 
vivo seeds of the same plants.  
 
MATERIALS AND METHODS  
General procedures  
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1H NMR (500 MHz, CD3OD) and
 13C NMR (125 
MHz, CD3OD) were recorded on a JEOL LA500 
MHz, Germany spectrometer with TMS as an 
internal standard. The FAB-MS spectrum was taken 
on a JEOL JMS_AX500 mass spectrometer MS-
FAB09A positive. HPLC was carried out on Agilent 
a series 1100 interface with stationary phase (RP18), 
injection volume (10 μl), oven temperature (25°C), 
diode array detector  (254 nm),  flow rate (1ml / min) 
and mobile phase: MeOH/H2O (1:1) under gradient 
conditions. Column chromatography was carried out 
on silica gel 60 (Merck; 230 - 400 mesh). TLC: pre-
coated silica gel 60F254 plates (Merck); CC: silica gel 
type 60 (Merck). MS: Murashige and Skoog medium 
(Duchefa Biochemie The Netherlands).  
 
Plant materials 
Immature seeds (IS) of T. neriifolia Juss. 
and T. thevetioides Kunth were collected from Al-
Orman garden, Giza, Egypt in March 2006. They 
were identified by Prof. Dr. K. H. El-Batanouny, 
Botany Department, Faculty of Science, Cairo 
University. Voucher specimens are deposited at the 
Herbarium of NRC, Dokki, Cairo, Egypt. 
 
Authentic compounds 
The reference of cardiac glycosides 
(peruvoside and neriifolin) were purchased from 
Sigma Chemicals Co., St. louis Mo. USA. Thevetin B 
and digitoxigenin were separated and identified 
throughout this work. 
 
Initition of IS calli cultures 
Calli cultures of T. neriifolia and T. 
thevetioides derived IS were performed as described 
by Taha et al. (2010). 
 
Extraction and isolation of cardiac glycosides 
In vitro derived calli of T. neriifolia and T. 
thevetioides and in vivo IS were lyophilized and 
powdered. Then they were percolated in methanol 
(3x3L) at room temperature for 24 hrs and filtered. 
The percolation was repeated three times and the 
methanolic extracts for each plant were combined 
and evaporated in vacuo at 45 ºC. The dry crude 
extract was defatted with petroleum ether. The 
residue was dissolved in MeOH/H2O (1:1) and 
extracted with chloroform. The chloroform extracts 
were combined together, dehydrated and the solvent 
distilled of in vacuo at 45 ºC to give total 
cardenolides (Fried and Sherma, 1994 and Abdel-
Azim et al., 1996).  
 
Identification of the isolated compounds 
All isolated compounds were identified by 
FAB-MS, 1H-NMR and 13C NMR spectroscopy. 
Furthermore, the determination of cardiac glycosides 
was carried out using co-chromatography TLC and 




One gram each of air-dried powdered of in 
vivo and in vitro   derived calli of IS of T. neriifolia 
and T. thevetioides was accurately weighed. Each 
sample was extracted with 50 ml 70% MeOH till 
exhaustion. The obtained methanolic extract was 
evaporated till dryness. The residue was re-dissolved 
in 1 mL methanol and filtered. The filtrate was used 
for quantitative determination of the isolated 
compounds using HPLC (10 µL was injected). 
Which, then they were performed on RP18 column 
using water (A) and methanol (B) as solvents and 
detected at the wave length of 220 nm. The following 
gradient was employed: 10% B for 25 minutes, 100% 
B within 30 minutes, then isocratic elution at 20% B 
for 20 minutes. Standard curves of authentic 
compounds and calculations of unknown amounts of 
cardiac glycosides in calli and regenerated culture 
samples were done using routine protocols as 
described by Scott (1996).  
 
Statistical analysis of data 
          All experiments were statistically analyzed 
using the F-test according to Steel and Torrie (1960). 
ANOVA was determined and the LSD was calculated 
at P=0.05. The data presented are the means of five 
replicates ± standard error (SE). 
 
RESULTS AND DISCUSSION 
Isolation and structure elucidation   
The crude cardenolides extract (5 g) were 
applied onto the top of a silica gel column 50x5 cm. 
Elution was carried out using CHCl3 followed by 
gradual increasing of the proportions of MeOH till 
100% MeOH. The course of the chromatographic 
fractions (100 ml each) was monitored by silica gel 
for TLC and developed using solvent system CHCl3: 
MeOH (8:2). The chromatoplats were visualized 
using Kedde’s reagent (Wagner and Bladt 1995), 
which give violet colour with cardiac glycosides. 
Similar fractions were combined and concentrated to 
dryness under reduced pressure. Thevetin B 
(compound I) was isolated in a pure form T. 
neriifolia and having Rf values 0.12. Also 
digitoxigenin (compound II) was isolated from T. 
thevetioides and having Rf values 0.81. 
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Compound I was identified as thevetin B 
(Fig. 1) by comparing its spectroscopic 
measurements with that published with Rodrigo et al. 
(2005). Its FAB-MS (positive mode) spectrum 
showed a molecular ion peak at m/z 858 (calcd. 
858.96), which is corresponding to the molecular 
formula C42H66O18.
 1H- NMR spectrum (CD3OD), 
showed two methyl protons at δ 0.8 and 0.9 
corresponding to C18 and C19, respectively. Signals 
due to the cardenolides ring were identified at δ 5.00 
(H21α), 4.8 (H21β) and 5.8 (H22). In addition to the 
signal detected at δ 2.7, which is corresponding to 
H17. The three anomeric protons of the three sugar 
units were identifies at δ 4.3, 4.5 and 5.11, 
respectively. The oxygenated methines were also 
identified at δ 3.54 for H3 and δ 3.54 for C-3'-OMe.  
 
Compound (II) 
Compound II was identified as digitoxigenin 
(Fig. 1) by comparing its spectroscopic 
measurements with that published with Rodrigo et al. 
(2005). Its FAB-MS (positive mode) showed a 
fragment ion peak at m/z 374.25 (calcd 374.51), 
which is corresponding to the molecular formula 
C23H34O3. 
1H- NMR spectrum (CD3OD), showed two 
methyl signals at δ 1.05 and 0.99 corresponding to 
H18 and H19, respectively.  Signals due to the 
cardenolides ring were identified at δ 6.15 (H22), 5.06 
(H21 α) and 4.67 (H21 β), in addition to H17 at δ 2.84. 
13C-NMR spectrum (CD3OD), showed an ester 
carbonyl at δ 172.1 (C23) and the vinylic carbons 
were identified at δ 117.7 (C22) and 172.0 (C20). 
Additional oxygenated carbons were observed for C14 
(δ 86.0) and C21 (δ 75.8). Also, the two methyl 
carbons were identified at δ 16.4 (C18) and δ 24.1 
(C19).  
The results obtained are in agreement with 
those reported by Mahran et al. (1971), who isolated 
thevetin B from seeds of T. neriifolia, and Perez et al. 
(1993), who isolated digitoxigenin from seeds of T. 
thevetioides. 
 
Inititation of  IS calli cultures   
The highest value of IS calli of T. neriifolia 
and T. thevetioides  (Fig. 2 A and B) was recorded 
with  MS+ 1mg/l 2,4-D + 3mg/l Kin as described by 
Taha et al. (2010). 
 
Qualitative and quantitative determination of 
cardenolides 
1. Qualitative determination  
TLC chromatoplates as a preliminary 
screening to check the presence of the examined 
cardenolids compounds in calli and regenerated 
shootlet extracts. The chloroform extracts were 
compared with authentic samples using system 
solvent chloform/methanol (8:2) and visualized with 
Kedde’s reagent. The spots corresponding to Rf 
values 0.12, 0.60, 0.67 and 0.81 were referred to 
thevetin B, neriifolin, peruvoside and, digitoxigenin, 
respectively. The four compounds were detected in 
all the examined calli and regenerated shootlet 
extracts. 
 
2. Quantitative determination (HPLC technique) 
As shown in Table 1 thevetin B, 
digitoxigenin, peruvoside and neriifolin in vivo and in 
vitro  seeds cultures  of T. neriifolia and T. 
thevetioides were illustrated in (Table 1). The amount 
of thevetin B, digitoxigenin, peruvoside and 
neriifolin of in vivo seeds of  T. neriifolia plant were 
0.19, 0.11, 0.39 and 0.25 mg/g DW, respectively. On 
the other hand, the amount of these compounds of in 
vivo seeds of T. thevetioides plant were 0.99, 0.15, 
0.24 and 0.39 mg/g DW, respectively. The highest 
concentration of thevetin B (85 mg/g DW) and 
digitoxigenin (0.028 mg/g DW) was recorded  in T. 
neriifolia IS calli cultures and that of peruvoside 
(0.017 mg/g DW) and neriifolin (0.032 mg/g DW) 
was found in T. thevetioides . 
Concerning, the accumulation of 
cardenolides in T. neriifolia calli cultures and in close 
of our obtained results Dantas et al. 1994 and Lopes 
et al. 2001 reported that some compounds of 
cardenolides were accumulated in cultured cells of T. 
neriifolia. Morevor, some studies by Fett-Netto et al. 
(1992) reported that 2,4-D and Kin combination were 
more effective in accumulation of secondary 
metabolites viz. taxol and related taxanes in cell 
suspension of Taxus species. It is interesting to note 
that the technique used in this experiment, together 
with other reported techniques e.g. callus and cell 
suspension cultures (Stuhlemmer et al. 1993) can be 
offered alternative sources for large scale production 
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Table 1: Concentrations of the cardiac glycosides (mg/g DW) 
 
Extract Thevetin B Digitoxigenin Peruvoside Neriifolin 
In vivo seeds*  0.19 0.12 0.39 0.25 
In vivo seeds**  0.99 0.15 0.24 0.39 
IS calli cultures*  0.085 0.028 0.013 0.019 
IS calli cultures ** 0.047 0.027 0.017 0.032 
where:  
Thevetin B (Rt = 9.48), digitoxigenin (Rt = 11.01), peruvoside (Rt = 11.32)  
and neriifolin (Rt = 12.72).   
(*) T. neriifolia; (**) T. thevetioides 
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